Bristlecone Advisors’s Idexx Laboratories IDXX Stock Holding History

Bristlecone Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$256K	Hold	401	–	–	0.02%	216
2025 Q2	$215K	Buy	+401	New	+$192K	0.02%	217
2025 Q1	–	Sell	-506	Closed	-$209K	–	380
2024 Q4	$209K	Hold	506	–	–	0.02%	273
2024 Q3	$256K	Hold	506	–	–	0.02%	251
2024 Q2	$247K	Hold	506	–	–	0.02%	252
2024 Q1	$273K	Hold	506	–	–	0.02%	242
2023 Q4	$281K	Hold	506	–	–	0.03%	235
2023 Q3	$221K	Hold	506	–	–	0.02%	246
2023 Q2	$254K	Hold	506	–	–	0.03%	236
2023 Q1	$253K	Hold	506	–	–	0.03%	232
2022 Q4	$206K	Buy	+506	New	+$196K	0.03%	250

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Bristlecone Advisors's IDXX Position: Q3 2025 in Review

Bristlecone Advisors held its Idexx Laboratories (IDXX) position steady in Q3 2025 at 401 shares worth $256K. The position accounts for 0.02% of the portfolio, ranked #216.

Bristlecone Advisors first reported a position in IDXX in Q4 2022 and has held it in 11 quarters since. The position peaked at $281K in Q4 2023. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.

Bristlecone Advisors held 401 shares of Idexx Laboratories worth $256K as of Q3 2025.
Bristlecone Advisors left its Idexx Laboratories share count unchanged in Q3 2025.
Idexx Laboratories made up 0.02% of Bristlecone Advisors's portfolio in Q3 2025, its #216 holding.
Bristlecone Advisors first reported a position in Idexx Laboratories in Q4 2022 and has held it in 11 quarters since.
Bristlecone Advisors's Idexx Laboratories position peaked at $281K in Q4 2023.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.

Based on Bristlecone Advisors's 13F filing for Q3 2025, filed 24 Oct 2025.